-+ 0.00%
-+ 0.00%
-+ 0.00%

Faron Pharmaceuticals Approves New Share Issuance for Convertible Bond Payment

MT Newswires·12/03/2025 06:26:35
Listen to the news
06:26 AM EST, 12/03/2025 (MT Newswires) -- Faron Pharmaceuticals (FARON.HE, FARN.L) approved the issuance of new shares via the exercise of 517,795 special rights for the amortization payment of senior unsecured convertible bonds worth 15 million euros. The pharmaceutical company issued 517,795 new shares for an aggregate subscription price of 965,998.35 euros on Tuesday, according to a Wednesday release. The exercise follows the receipt of a scheduled amortized payment notice from the bondholder.